Farmamondo approves Normokineztine in Russia!

FarmaMondo approves Normokineztine in Russian Federation for Huntington disease patients. The product, license to FarmaMondo from AOP Orphan, has been approved as the sole indicated therapy currently available for Russian patients suffering from the indicated disease. FarmaMondo will launch the product in H1 2016 through a dedicated campaign with relevant KOL.